What is a stock summary page? Click here for an overview.
Business Description
Novelix Pharmaceuticals Ltd
ISIN : INE314I01036
Compare
Compare
Traded in other countries / regions
536565.India IPO Date
2009-03-25Description
Novelix Pharmaceuticals Ltd formerly Trimurthi Ltd is an India based pharmaceutical supplier. It operates as a holding company, which engages in the distribution, retail, and marketing of pharmaceutical products. It operates through the following business segments: Pharma Business, Financial Activity, Investment Activity, Foods, and Trading in Shares. Its products include medicine for contraception, obstetrics and gynecology, digestive system, and other areas.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.74 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 6.45 | |||||
| Beneish M-Score | -1.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -23 | |||||
| 3-Year EBITDA Growth Rate | 68.4 | |||||
| 3-Year Book Growth Rate | 2.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 100 | |||||
| 9-Day RSI | 100 | |||||
| 14-Day RSI | 100 | |||||
| 3-1 Month Momentum % | 4.97 | |||||
| 6-1 Month Momentum % | 15.7 | |||||
| 12-1 Month Momentum % | 47.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.71 | |||||
| Quick Ratio | 3.61 | |||||
| Cash Ratio | 0.12 | |||||
| Days Inventory | 30.32 | |||||
| Days Sales Outstanding | 46.65 | |||||
| Days Payable | 39.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 7.9 | |||||
| Operating Margin % | 1.71 | |||||
| Net Margin % | 1.87 | |||||
| FCF Margin % | -3.21 | |||||
| ROE % | 2.57 | |||||
| ROA % | 2.24 | |||||
| ROIC % | 3.26 | |||||
| 3-Year ROIIC % | -165.15 | |||||
| ROC (Joel Greenblatt) % | 15.81 | |||||
| ROCE % | 2.55 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 120.96 | |||||
| PE Ratio without NRI | 109.51 | |||||
| PS Ratio | 2.21 | |||||
| PB Ratio | 2.95 | |||||
| Price-to-Tangible-Book | 2.95 | |||||
| EV-to-EBIT | 131.22 | |||||
| EV-to-EBITDA | 118.86 | |||||
| EV-to-Revenue | 2.44 | |||||
| EV-to-FCF | -72.33 | |||||
| Price-to-GF-Value | 0.73 | |||||
| Price-to-Projected-FCF | 9.24 | |||||
| Price-to-Median-PS-Value | 2.73 | |||||
| Price-to-Graham-Number | 8.11 | |||||
| Price-to-Net-Current-Asset-Value | 3.01 | |||||
| Earnings Yield (Greenblatt) % | 0.76 | |||||
| FCF Yield % | -1.3 | |||||
| Forward Rate of Return (Yacktman) % | -33.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Novelix Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 107.004 | ||
| EPS (TTM) (₹) | 0.22 | ||
| Beta | 0.23 | ||
| 3-Year Sharpe Ratio | 0.84 | ||
| 3-Year Sortino Ratio | 1.64 | ||
| Volatility % | 37.61 | ||
| 14-Day RSI | 100 | ||
| 14-Day ATR (₹) | 0.053489 | ||
| 20-Day SMA (₹) | 25.98 | ||
| 12-1 Month Momentum % | 47.47 | ||
| 52-Week Range (₹) | 17.19 - 26.61 | ||
| Shares Outstanding (Mil) | 9.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Novelix Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Novelix Pharmaceuticals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Novelix Pharmaceuticals Ltd Frequently Asked Questions
What is Novelix Pharmaceuticals Ltd(BOM:536565)'s stock price today?
The current price of BOM:536565 is ₹26.61. The 52 week high of BOM:536565 is ₹26.61 and 52 week low is ₹17.19.
When is next earnings date of Novelix Pharmaceuticals Ltd(BOM:536565)?
The next earnings date of Novelix Pharmaceuticals Ltd(BOM:536565) is .
Does Novelix Pharmaceuticals Ltd(BOM:536565) pay dividends? If so, how much?
Novelix Pharmaceuticals Ltd(BOM:536565) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers